Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $112.03B | $110.59B | $113.22B | $113.16B | $111.62B | $108.54B | $100.81B | $100.82B |
| Cost of revenue | $75.36B | $73.49B | $82.04B | $79.96B | $78.59B | $73.41B | $67.04B | $65.96B |
| Gross profit | $36.67B | $37.10B | $31.17B | $33.20B | $33.03B | $35.13B | $33.77B | $34.86B |
| Gross margin | 32.7% | 33.5% | 27.5% | 29.3% | 29.6% | 32.4% | 33.5% | 34.6% |
| Selling, general and administrative | $14.27B | $15.39B | $18.11B | $16.32B | $13.78B | $13.59B | $13.54B | $14.32B |
| Operating expenses | $104.04B | $102.73B | $112.84B | $108.85B | $106.47B | $100.46B | $93.03B | $92.11B |
| Operating income | $7.99B | $7.86B | $380.00M | $4.32B | $5.15B | $8.09B | $7.77B | $8.71B |
| Operating margin | 7.1% | 7.1% | 0.3% | 3.8% | 4.6% | 7.4% | 7.7% | 8.6% |
| EBITDA | $9.03B | $8.89B | $1.50B | $5.41B | $6.23B | $9.15B | $8.81B | $9.75B |
| Interest expense | −$962.00M | −$955.00M | −$974.00M | −$1.00B | −$1.03B | −$998.00M | −$1.00B | −$1.07B |
| Income before taxes | $6.97B | $7.96B | −$720.00M | $3.23B | $4.08B | $8.11B | $6.79B | $7.61B |
| Income taxes | $1.30B | $1.48B | −$938.00M | $686.00M | $510.00M | $1.63B | $1.01B | $1.36B |
| Net income | $5.67B | $6.48B | $218.00M | $2.54B | $3.57B | $6.47B | $5.78B | $6.26B |
| Net margin | 5.1% | 5.9% | 0.2% | 2.2% | 3.2% | 6.0% | 5.7% | 6.2% |
| EPS, basic | $6.06 | $6.92 | $0.01 | $2.59 | $3.76 | $6.90 | $6.04 | $6.56 |
| EPS, diluted | $6.04 | $6.90 | $0.01 | $2.59 | $3.74 | $6.85 | $5.92 | $6.51 |
| Diluted shares | 906.00M | 910.00M | 908.00M | 908.00M | 910.00M | 918.00M | 936.00M | 930.00M |
Figures describe UnitedHealth shares, not any token. As of Aug 10, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.
